ORCL Jan 2024 42.500 call
| Previous close | 46.95 |
| Open | 46.95 |
| Bid | 43.75 |
| Ask | 46.15 |
| Strike | 42.50 |
| Expiry date | 2024-01-19 |
| Day's range | 46.95 - 46.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
- Motley Fool
5 Stocks Warren Buffett Bought Hand Over Fist as the Nasdaq Plunged
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).
- Zacks
Oracle (ORCL) Dips More Than Broader Markets: What You Should Know
Oracle (ORCL) closed the most recent trading day at $67.04, moving -1.84% from the previous trading session.
- PR Newswire
Oracle and NIH Networks Collaborate to Help End HIV
The HIV Vaccine Trials Network, funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the NIH, today launched a new HIV awareness campaign and the Red Ribbon Registry with the goal of helping end HIV. Built by Oracle, the unique cloud-based registry makes it easy for anyone to volunteer to be considered for an HIV clinical study – getting us one step closer to a cure. To learn more or volunteer for an HIV clinical study visit https://www.helpendhiv.org/.
